Market Overview

UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on HCC Insurance Holdings After 4Q12 Earnings

Related HCC
HCC Insurance Touches New 52-Week High - Analyst Blog
Update on Celsion's ThermoDox - Analyst Blog

In a report published Friday, Goldman Sachs reiterated its Neutral rating on HCC Insurance Holdings (NYSE: HCC), and raised its price target from $37.00 to $40.00.

Goldman Sachs noted, “We update our estimates for HCC following the 4Q12 conference call. We remain Neutral-rated. The company beat our estimates due to higher reserve development and slightly better underlying profitability, but results were otherwise in line. We are revising our estimates slightly higher to reflect higher underlying profitability in the A&H and Professional Liability segments. Also, our investment income estimates are modestly higher due to a slightly larger investment portfolio than we previously estimated, as the company continues to utilize its low-cost revolving credit facility to fund share buybacks.”

HCC Insurance Holdings closed on Thursday at $39.74.

Latest Ratings for HCC

DateFirmActionFromTo
Oct 2014JMP SecuritiesMaintainsMarket Outperform
Oct 2014JMP SecuritiesMaintainsMarket Outperform
Oct 2014Keefe Bruyette & WoodsMaintainsMarket Perform

View More Analyst Ratings for HCC
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCC)

Around the Web, We're Loving...

Get Benzinga's Newsletters